Viral hepatitis: Difference between revisions

No edit summary
 
(23 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
==Background==
===Hepatitis A===
*Hepatocellular pattern of injury, where AST and ALT are higher than Tbili and Alk Phos; likely to have significantly elevated ALT and AST (20x normal or higher)
*Most common form of transmission occurs from asymptomatic children to adults
*Of note, transmission of [[Hepatitis B]] and [[Hepatitis C]] through donated blood, blood products, and organs is rare in the US since blood screening became available in 1992
*Incubation period: 15-50d
*Prodrome: N/V, malaise, fever, abd pain
**1wk later bilirubinuria, clay-colored stool, jaundice
*Death from hepatic failure is rare


===Hepatitis B===
===Overview of Common Viral Hepatitis Agents===
*Incubation period: 1-3 months
*[[Hepatitis A]]
*Presentation is similar to hep A
**Fecal-oral transmission
*Lab tests:
**Associated with epidemics linked to a common source (water)
**HBsAg: + implies infection
**Most common risk factor is travel outside of the US <ref>Oyama, LC: Disorders of the Liver and Biliary Tractin Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 8. St. Louis, Mosby, Inc., 2014, (Ch) 107: p 1186-1204.</ref>
**Anti-HBs: implies clearance or vaccination
**Not associated with chronic carrier state; incubation period is approximately 30 days, and infectivity usually resolved prior to symptom onset
**Anti-HBc: Implies prior infection; IgM = acute & in flares; only marker in window period; IgG always present
**Most common form of transmission occurs from asymptomatic children to adults
**HBe-Ag: Implies active viral replication & infectivity
***Approximately only 5% of infected children symptomatic
**Anti-HBe: low infectivity
***Whereas ~75% of adults are symptomatic
**HBV DNA: Similar to HBe-Ag but more sensitive
**Incubation period: 15-50d
**Prodrome: [[nausea/vomiting]], malaise, [[fever]], [[abdominal pain]]
***1wk later: clay-colored stool, jaundice
**Death from [[hepatic failure]] is rare


===Hepatitis C===
*[[Hepatitis B]]
*Unlike Hep A and B, most often asymptomatic in acute phase of infection
**Transmitted parenterally, blood contact, and unprotected sex
*>75% of pts advance to chronic stage
**90% of exposed infants progress to chronic hepatitis; 10% of exposed adults progress to chronic hepatitis
*Active disease identified by reactive HCV ab and positive HCV RNA
**Serology<ref> www.cdc.gov/hepatitis </ref>
**Incubation period: 1-3 months
**Presentation is similar to hep A
**Lab tests:
***HBsAg: + implies infection
***Anti-HBs: implies clearance or vaccination
***Anti-HBc: Implies prior infection; IgM = acute & in flares; only marker in window period; IgG always present
***HBe-Ag: Implies active viral replication & infectivity
***Anti-HBe: low infectivity
***HBV DNA: Similar to HBe-Ag but more sensitive


===Hepatitis D===
*[[Hepatitis C]]
*Only currently with hepatitis B
**Blood-borne, in US, most commonly transmitted through [[IV drug use]]. Infrequently transmitted through sexual contact
*High incidence of cirrhosis
**90% of HCV infections progress to chronic hepatitis<ref>Oyama, LC: Disorders of the Liver and Biliary Tractin Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 8. St. Louis, Mosby, Inc., 2014, (Ch) 107: p 1186-1204</ref>
**Unlike Hep A and B, most often asymptomatic in acute phase of infection
**>75% of patients advance to chronic stage
**Active disease identified by reactive HCV ab and positive HCV RNA


===Hepatitis E===
*[[Hepatitis D]]
*Fecal-oral transmission
**Transmission similar to Hepatitis B
*No carrier state
**Can only co-infect patients with Hepatitis B (actively producing HBsAg)
*High associated mortality
**Presentation can range from acute self-limited disease to fulminant hepatitis or chronic infection
**Only occurs with comorbid hepatitis B
**High incidence of cirrhosis
 
*[[Hepatitis E]]
**Fecal-oral transmission
**Usually results in mild illness, but can cause fulminant hepatitis in pregnant women<ref>Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The Global Burden of Hepatitis E Virus Genotypes 1 and 2 in 2005. Hepatology, Vol. 55, No. 4, 2012: 988-997</ref>
**Fecal-oral transmission
**No carrier state
**High associated mortality
**Common in Southeast Asia, but different genotypes found globally across Asia, Africa, Latin America<ref>Chaudhry SA et al. Hepatitis E infection during pregnancy. Can Fam Physician. 2015 Jul; 61(7): 607–608.</ref>
**Mortality in pregnancy dependent on trimester<ref>Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother to child transmission [article in French] Pathol Biol (Paris) 2002;50(9):568–75.</ref>
***1.5% in first trimester
***8.5% in second trimester
***21% in third trimester


==Clinical Features==
==Clinical Features==
Line 38: Line 63:
{{Acute hepatitis causes}}
{{Acute hepatitis causes}}


==Diagnosis==
==Evaluation==
*Hepatitis panel, which typically consists of:
*[[LFTs]]
**HepA-Ab, IgM
*INR
**HBsAg
**[[liver disease induced coagulopathy|Coagulopathy]] correlates w/more severe liver dysfunction
**HBc-Ab, IgM
*Acute hepatitis panel
**HC-Ab
**Hep A Ab IgM
**Hep B cAb IgM
**Hep B sAg
**Hep B sAb
**Hep C Ab


==Treatment==
{{Acute hepatitis panel}}
*Household or close contacts of positive HepA individual may require IM HepA Ig if within 14 days of exposure
 
==Management==
*Supportive care
**Symptomatic management; [[antiemetics]], [[pain control]], [[IVF|rehydration]]
**Manage any complications of [[liver failure|liver dysfunction]] and/or [[cirrhosis]]
**Avoid hepatotoxic meds
*HepA: Household or close contacts may require IM HepA Ig if within 14 days of exposure
*See also [[Hepatitis B post-exposure prophylaxis]]
*Outpatient treatments for HCV include [[Interferon-α]], [ribavirin]], and newer direct acting antivirals (e.g. Harvoni)


==Disposition==
==Disposition==
===Admit Criteria===
*Admit
*INR >2
**INR >2
*Unable to tolerate POs
**Unable to tolerate PO
*Pain control
**Intractable pain
*Bilirubin >30
**Bilirubin >30
*[[Hypoglycemia]]
**[[Hypoglycemia]]
*Significant comorbid illness/immunocomp
**Significant comorbidity/immunocompromised
*>50 years
**Age >50 years


==See Also==
==See Also==
*[[Jaundice]]
*[[Jaundice]]
*[[Acute Hepatitis]]
*[[Acute Hepatitis]]
*[[Acute hepatic failure]]


==References==
==References==
 
<references/>


[[Category:GI]]
[[Category:GI]]
[[Category:ID]]
[[Category:ID]]

Latest revision as of 18:11, 4 June 2020

Background

  • Hepatocellular pattern of injury, where AST and ALT are higher than Tbili and Alk Phos; likely to have significantly elevated ALT and AST (20x normal or higher)
  • Of note, transmission of Hepatitis B and Hepatitis C through donated blood, blood products, and organs is rare in the US since blood screening became available in 1992

Overview of Common Viral Hepatitis Agents

  • Hepatitis A
    • Fecal-oral transmission
    • Associated with epidemics linked to a common source (water)
    • Most common risk factor is travel outside of the US [1]
    • Not associated with chronic carrier state; incubation period is approximately 30 days, and infectivity usually resolved prior to symptom onset
    • Most common form of transmission occurs from asymptomatic children to adults
      • Approximately only 5% of infected children symptomatic
      • Whereas ~75% of adults are symptomatic
    • Incubation period: 15-50d
    • Prodrome: nausea/vomiting, malaise, fever, abdominal pain
      • 1wk later: clay-colored stool, jaundice
    • Death from hepatic failure is rare
  • Hepatitis B
    • Transmitted parenterally, blood contact, and unprotected sex
    • 90% of exposed infants progress to chronic hepatitis; 10% of exposed adults progress to chronic hepatitis
    • Serology[2]
    • Incubation period: 1-3 months
    • Presentation is similar to hep A
    • Lab tests:
      • HBsAg: + implies infection
      • Anti-HBs: implies clearance or vaccination
      • Anti-HBc: Implies prior infection; IgM = acute & in flares; only marker in window period; IgG always present
      • HBe-Ag: Implies active viral replication & infectivity
      • Anti-HBe: low infectivity
      • HBV DNA: Similar to HBe-Ag but more sensitive
  • Hepatitis C
    • Blood-borne, in US, most commonly transmitted through IV drug use. Infrequently transmitted through sexual contact
    • 90% of HCV infections progress to chronic hepatitis[3]
    • Unlike Hep A and B, most often asymptomatic in acute phase of infection
    • >75% of patients advance to chronic stage
    • Active disease identified by reactive HCV ab and positive HCV RNA
  • Hepatitis D
    • Transmission similar to Hepatitis B
    • Can only co-infect patients with Hepatitis B (actively producing HBsAg)
    • Presentation can range from acute self-limited disease to fulminant hepatitis or chronic infection
    • Only occurs with comorbid hepatitis B
    • High incidence of cirrhosis
  • Hepatitis E
    • Fecal-oral transmission
    • Usually results in mild illness, but can cause fulminant hepatitis in pregnant women[4]
    • Fecal-oral transmission
    • No carrier state
    • High associated mortality
    • Common in Southeast Asia, but different genotypes found globally across Asia, Africa, Latin America[5]
    • Mortality in pregnancy dependent on trimester[6]
      • 1.5% in first trimester
      • 8.5% in second trimester
      • 21% in third trimester

Clinical Features

Acute Hepatitis Features

Jaundice of the skin
Pediatric jaundice with icterus of sclera.

Differential Diagnosis

Causes of acute hepatitis

Evaluation

  • LFTs
  • INR
  • Acute hepatitis panel
    • Hep A Ab IgM
    • Hep B cAb IgM
    • Hep B sAg
    • Hep B sAb
    • Hep C Ab

Interpreting Acute Hepatitis Panel Results

Anti-hepatitis A, IgM Hepatitis B surface antigen Anti-hepatitis B core, IgM Anti-hepatitis C Interpretation
Positive Negative Negative Negative Acute hepatitis A
Negative Positive Positive Negative Acute hepatitis B
Negative Positive Negative Negative Chronic hepatitis B infection
Negative Negative Positive Negative Acute hepatitis B; quantity of hepatitis B surface antigen is too low to detect
Negative Negative Negative Positive Acute or chronic hepatitis C; additional tests are required to make the determination

Management

Disposition

  • Admit
    • INR >2
    • Unable to tolerate PO
    • Intractable pain
    • Bilirubin >30
    • Hypoglycemia
    • Significant comorbidity/immunocompromised
    • Age >50 years

See Also

References

  1. Oyama, LC: Disorders of the Liver and Biliary Tractin Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 8. St. Louis, Mosby, Inc., 2014, (Ch) 107: p 1186-1204.
  2. www.cdc.gov/hepatitis
  3. Oyama, LC: Disorders of the Liver and Biliary Tractin Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 8. St. Louis, Mosby, Inc., 2014, (Ch) 107: p 1186-1204
  4. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The Global Burden of Hepatitis E Virus Genotypes 1 and 2 in 2005. Hepatology, Vol. 55, No. 4, 2012: 988-997
  5. Chaudhry SA et al. Hepatitis E infection during pregnancy. Can Fam Physician. 2015 Jul; 61(7): 607–608.
  6. Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother to child transmission [article in French] Pathol Biol (Paris) 2002;50(9):568–75.
  7. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.